» Articles » PMID: 37118755

Partial Erosion on Under-methylated Regions and Chromatin Reprogramming Contribute to Oncogene Activation in IDH Mutant Gliomas

Overview
Publisher Biomed Central
Specialties Biochemistry
Genetics
Date 2023 Apr 28
PMID 37118755
Authors
Affiliations
Soon will be listed here.
Abstract

Background: IDH1/2 hotspot mutations are well known to drive oncogenic mutations in gliomas and are well-defined in the WHO 2021 classification of central nervous system tumors. Specifically, IDH mutations lead to aberrant hypermethylation of under-methylated regions (UMRs) in normal tissues through the disruption of TET enzymes. However, the chromatin reprogramming and transcriptional changes induced by IDH-related hypermethylation in gliomas remain unclear.

Results: Here, we have developed a precise computational framework based on Hidden Markov Model to identify altered methylation states of UMRs at single-base resolution. By applying this framework to whole-genome bisulfite sequencing data from 75 normal brain tissues and 15 IDH mutant glioma tissues, we identified two distinct types of hypermethylated UMRs in IDH mutant gliomas. We named them partially hypermethylated UMRs (phUMRs) and fully hypermethylated UMRs (fhUMRs), respectively. We found that the phUMRs and fhUMRs exhibit distinct genomic features and chromatin states. Genes related to fhUMRs were more likely to be repressed in IDH mutant gliomas. In contrast, genes related to phUMRs were prone to be up-regulated in IDH mutant gliomas. Such activation of phUMR genes is associated with the accumulation of active H3K4me3 and the loss of H3K27me3, as well as H3K36me3 accumulation in gene bodies to maintain gene expression stability. In summary, partial erosion on UMRs was accompanied by locus-specific changes in key chromatin marks, which may contribute to oncogene activation.

Conclusions: Our study provides a computational strategy for precise decoding of methylation encroachment patterns in IDH mutant gliomas, revealing potential mechanistic insights into chromatin reprogramming that contribute to oncogenesis.

References
1.
Maeder M, Angstman J, Richardson M, Linder S, Cascio V, Tsai S . Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nat Biotechnol. 2013; 31(12):1137-42. PMC: 3858462. DOI: 10.1038/nbt.2726. View

2.
Rizzardi L, Hickey P, Rodriguez DiBlasi V, Tryggvadottir R, Callahan C, Idrizi A . Neuronal brain-region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability. Nat Neurosci. 2019; 22(2):307-316. PMC: 6348048. DOI: 10.1038/s41593-018-0297-8. View

3.
Tate J, Bamford S, Jubb H, Sondka Z, Beare D, Bindal N . COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 2018; 47(D1):D941-D947. PMC: 6323903. DOI: 10.1093/nar/gky1015. View

4.
Venteicher A, Tirosh I, Hebert C, Yizhak K, Neftel C, Filbin M . Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science. 2017; 355(6332). PMC: 5519096. DOI: 10.1126/science.aai8478. View

5.
Yin Y, Morgunova E, Jolma A, Kaasinen E, Sahu B, Khund-Sayeed S . Impact of cytosine methylation on DNA binding specificities of human transcription factors. Science. 2017; 356(6337). PMC: 8009048. DOI: 10.1126/science.aaj2239. View